全文获取类型
收费全文 | 450篇 |
免费 | 40篇 |
出版年
2023年 | 4篇 |
2022年 | 13篇 |
2021年 | 31篇 |
2020年 | 11篇 |
2019年 | 16篇 |
2018年 | 16篇 |
2017年 | 16篇 |
2016年 | 25篇 |
2015年 | 31篇 |
2014年 | 21篇 |
2013年 | 24篇 |
2012年 | 30篇 |
2011年 | 22篇 |
2010年 | 22篇 |
2009年 | 13篇 |
2008年 | 20篇 |
2007年 | 19篇 |
2006年 | 15篇 |
2005年 | 9篇 |
2004年 | 10篇 |
2003年 | 9篇 |
2002年 | 11篇 |
2001年 | 9篇 |
2000年 | 4篇 |
1999年 | 4篇 |
1998年 | 7篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 4篇 |
1994年 | 4篇 |
1993年 | 3篇 |
1992年 | 12篇 |
1991年 | 5篇 |
1990年 | 6篇 |
1989年 | 7篇 |
1987年 | 2篇 |
1984年 | 3篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1974年 | 1篇 |
1973年 | 4篇 |
1972年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1967年 | 2篇 |
1965年 | 1篇 |
排序方式: 共有490条查询结果,搜索用时 93 毫秒
481.
482.
483.
484.
O. Zethner Bashir M. Khan M. Ismail Chaudhry B. Bolet Sharfuddin Khan Habibullah Khan Hanif Gul L. Øgaard M. Zaman Gul Nawaz 《BioControl》1987,32(5):449-455
Agrotis segetum Schiff granulosis virus (AsGV) propagated in Denmark was supplied against naturally occurring cutworm populations (A. ipsilon and to a less extentA. segetum) in experimental field plots of tobacco, okra, potato and sugar beet in northern Pakistan. AsGV doses varied between 4 ×
107 and 4 × 1011 capsules per m2 plot, and no. of applications between 1 and 3.
One treatment with AsGV did not reduce cutworm damage significantly to tobacco seedlings and potato plants.
Two treatments with AsGV reduced cutworm damage significantly. In tobacco, reduction was 64–82%, in okra and potato 85% and
77% respectively. Damage in sugar beet was reduced 78%.
Three treatments with AsGV dis not reduce damage significantly better than two treatments.
AsGV and the chemical insecticides Tamaran and Dieldrin, andBacillus thuringiensis (Thuricide) were about equally effective, reducing damage by 85%, 79%, 87% and 69%, respectively. No difference was found
between the efficiency of highly purified AsGV to which activated charcoal was added and partially purified AsGV without charcoal.
相似文献
485.
486.
Mir Zaman Hussain Stephen K. Hamilton G. Philip Robertson 《Global Change Biology Bioenergy》2023,15(2):254-263
Without fertilization, harvest of perennial bioenergy cropping systems diminishes soil nutrient stocks, yet the time course of nutrient drawdown has not often been investigated. We analyzed phosphorus (P) inputs (fertilization and atmospheric deposition) and outputs (harvest and leaching losses) over 7 years in three representative biomass crops—switchgrass (Panicum virgatum L.), miscanthus (Miscanthus × giganteus) and hybrid poplar trees (Populus nigra × P. maximowiczii)—as well as in no-till corn (maize; Zea mays L.) for comparison, all planted on former cropland in SW Michigan, USA. Only corn received P fertilizer. Corn (grain and stover), switchgrass, and miscanthus were harvested annually, while poplar was harvested after 6 years. Soil test P (STP; Bray-1 method) was measured in the upper 25 cm of soil annually. Harvest P removal was calculated from tissue P concentration and harvest yield (or annual woody biomass accrual in poplar). Leaching was estimated as total dissolved P concentration in soil solutions sampled beneath the rooting depth (1.25 m), combined with hydrological modeling. Fertilization and harvest were by far the dominant P budget terms for corn, and harvest P removal dominated the P budgets in switchgrass, miscanthus, and poplar, while atmospheric deposition and leaching losses were comparatively insignificant. Because of significant P removal by harvest, the P balances of switchgrass, miscanthus, and poplar were negative and corresponded with decreasing STP, whereas P fertilization compensated for the harvest P removal in corn, resulting in a positive P balance. Results indicate that perennial crop harvest without P fertilization removed legacy P from soils, and continued harvest will soon draw P down to limiting levels, even in soils once heavily P-fertilized. Widespread cultivation of bioenergy crops may, therefore, alter P balances in agricultural landscapes, eventually requiring P fertilization, which could be supplied by P recovery from harvested biomass. 相似文献
487.
MS Nandhu Jes Paul Korah P Kuruvilla Anitha Malat Chinthu Romeo CS Paulose 《Journal of biomedical science》2011,18(1):5
Parkinson's disease is characterized by progressive cell death in the substantia nigra pars compacta, which leads to dopamine
depletion in the striatum and indirectly to cortical dysfunction. Increased glutamatergic transmission in the basal ganglia
is implicated in the pathophysiology of Parkinson's disease and glutamate receptor mediated excitotoxicity has been suggested
to be one of the possible causes of the neuronal degeneration. In the present study, the effects of serotonin, gamma-aminobutyric
acid and bone marrow cells infused intranigrally to substantia nigra individually and in combination on unilateral 6-hydroxydopamine
induced Parkinson's rat model was analyzed. Scatchard analysis of total glutamate and NMDA receptor binding parameters showed
a significant increase in Bmax (P < 0.001) in the cerebral cortex of 6-hydroxydopamine infused rat compared to control. Real Time PCR amplification of NMDA2B,
mGluR5, bax, and ubiquitin carboxy-terminal hydrolase were up regulated in cerebral cortex of 6-hydroxydopamine infused rats
compared to control. Gene expression studies of GLAST, ά-Synuclien and Cyclic AMP response element-binding protein showed
a significant (P < 0.001) down regulation in 6-OHDA infused rats compared to control. Behavioural studies were carried out
to confirm the biochemical and molecular studies. Serotonin and GABA along with bone marrow cells in combination showed reversal
of glutamate receptors and behaviour abnormality shown in the Parkinson's rat model. The therapeutic significance in Parkinson's
disease is of prominence. 相似文献
488.
Changfu Yao Stephanie A. Bora Tanyalak Parimon Tanzira Zaman Oren A. Friedman Joseph A. Palatinus Nirmala S. Surapaneni Yuri P. Matusov Giuliana Cerro Chiang Alexander G. Kassar Nayan Patel Chelsi E.R. Green Adam W. Aziz Harshpreet Suri Jo Suda Andres A. Lopez Gislâine A. Martins Barry R. Stripp Peter Chen 《Cell reports》2021,34(1):108590
- Download : Download high-res image (182KB)
- Download : Download full-size image
489.
490.
Guillaume Butler-Laporte Tomoko Nakanishi Vincent Mooser David R. Morrison Tala Abdullah Olumide Adeleye Noor Mamlouk Nofar Kimchi Zaman Afrasiabi Nardin Rezk Annarita Giliberti Alessandra Renieri Yiheng Chen Sirui Zhou Vincenzo Forgetta J. Brent Richards 《PLoS medicine》2021,18(6)
BackgroundIncreased vitamin D levels, as reflected by 25-hydroxy vitamin D (25OHD) measurements, have been proposed to protect against COVID-19 based on in vitro, observational, and ecological studies. However, vitamin D levels are associated with many confounding variables, and thus associations described to date may not be causal. Vitamin D Mendelian randomization (MR) studies have provided results that are concordant with large-scale vitamin D randomized trials. Here, we used 2-sample MR to assess evidence supporting a causal effect of circulating 25OHD levels on COVID-19 susceptibility and severity.Methods and findingsGenetic variants strongly associated with 25OHD levels in a genome-wide association study (GWAS) of 443,734 participants of European ancestry (including 401,460 from the UK Biobank) were used as instrumental variables. GWASs of COVID-19 susceptibility, hospitalization, and severe disease from the COVID-19 Host Genetics Initiative were used as outcome GWASs. These included up to 14,134 individuals with COVID-19, and up to 1,284,876 without COVID-19, from up to 11 countries. SARS-CoV-2 positivity was determined by laboratory testing or medical chart review. Population controls without COVID-19 were also included in the control groups for all outcomes, including hospitalization and severe disease. Analyses were restricted to individuals of European descent when possible. Using inverse-weighted MR, genetically increased 25OHD levels by 1 standard deviation on the logarithmic scale had no significant association with COVID-19 susceptibility (odds ratio [OR] = 0.95; 95% CI 0.84, 1.08; p = 0.44), hospitalization (OR = 1.09; 95% CI: 0.89, 1.33; p = 0.41), and severe disease (OR = 0.97; 95% CI: 0.77, 1.22; p = 0.77). We used an additional 6 meta-analytic methods, as well as conducting sensitivity analyses after removal of variants at risk of horizontal pleiotropy, and obtained similar results. These results may be limited by weak instrument bias in some analyses. Further, our results do not apply to individuals with vitamin D deficiency.ConclusionsIn this 2-sample MR study, we did not observe evidence to support an association between 25OHD levels and COVID-19 susceptibility, severity, or hospitalization. Hence, vitamin D supplementation as a means of protecting against worsened COVID-19 outcomes is not supported by genetic evidence. Other therapeutic or preventative avenues should be given higher priority for COVID-19 randomized controlled trials.In a Mendelian randomization analysis, Guillaume Butler-Laporte, Tomoki Nakanishi, and colleages study genetic evidence for a relationship between vitamin D and COVID-19 outcomes. 相似文献